Rudolf Andrýs

Pyridinium Oximes with<i>Ortho</i>-Positioned Chlorine Moiety Exhibit Improved Physicochemical Properties and Efficient Reactivation of Human Acetylcholinesterase Inhibited by Several Nerve Agents

Tamara Zorbaz, David Maliňák, Nikola Maraković et al. · Journal of Medicinal Chemistry · 2018 · 62 citations · Full text

Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy

Irène Pachón-Angona, Bernard Refouvelet, Rudolf Andrýs et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 56 citations · Full text

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy

Barbara Kaproń, Robert Czarnomysy, Mariusz Wysokiński et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2020 · 55 citations · Full text

Pharmacological Study, Medicine, Hz Model +14

2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease

Eva Mezeiová, Jana Janočková, Rudolf Andrýs et al. · European Journal of Medicinal Chemistry · 2020 · 36 citations · Full text

Medicinal Chemistry, Alzheimer's Disease, Medicine +11

(±)-<b>BIGI-3h</b>: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer’s Disease

Lhassane Ismaïli, Julie Monnin, Adeline Etiévant et al. · ACS Chemical Neuroscience · 2021 · 33 citations · Full text